Waiting
Login-Verarbeitung ...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Immunology and Infection / Generation of Knock-out Primary and Expanded…
JoVE Journal
Immunology and Infection

Ein Abonnement für JoVE ist erforderlich, um diesen Inhalt ansehen zu können. Melden Sie sich an oder starten Sie Ihre kostenlose Testversion.

JoVE Journal Immunology and Infection
Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins
 

Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins

Article DOI: 10.3791/58237-v • 07:26 min • June 14th, 2018
June 14th, 2018 •
1, 2, 1, 3, 1, 1, 1, 1, 1, 1, 1, 3, 1
1Center for Childhood Cancer and Blood Disease, Nationwide Children's Hospital, 2Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, 3Center for Clinical and Translational Research, Nationwide Children's Hospital Research Institute

Kapitel

Summary
Automatic Translation

Here, we present a protocol to genetically modify primary or expanded human natural killer (NK) cells using Cas9 Ribonucleoproteins (Cas9/RNPs). By using this protocol, we generated human NK cells deficient for transforming growth factor–b receptor 2 (TGFBR2) and hypoxanthine phosphoribosyltransferase 1 (HPRT1).

Tags

Knock-out Primary NK Cells Expanded NK Cells Cas9 Ribonucleoproteins Gene Function Effector Cell Function High Success Rate DNA-dependent Approaches Clinically Relevant Genes NK Cell Therapy Immunotherapy Solid Tumors Brain Tumors TGF-beta Expression Transduction RPMI Medium IL2 Supplementation T75 Flask IL21-expressing K562 Feeder Cells Electroporation
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter